JESSICA BACON: Open Payments
NPI 1952081119 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 43 payments from 14 companies in 2025. Trend: 2023 $487 · 2024 $1,222 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $206 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| ABBVIE INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 5 | $72 |
| Exact Sciences Corporation | 4 | $66 |
| PFIZER INC. | 3 | $51 |
| Currax Pharmaceuticals LLC | 2 | $35 |
| Grifols USA, LLC | 1 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 2 | $31 |
Products named: Ozempic, FARXIGA, Cologuard Collection Kit, AIRSUPRA, NURTEC ODT, TRELEGY ELLIPTA, VRAYLAR, UBRELVY.
Industry payments across NC — which companies pay providers there.
